Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures? is a research paper published in Clinical Rheumatology (2020). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: K23AR067889
National Institutes of Health
Grant: K24AR063120-07
National Institutes of Health
Grant: R01 AR073208
National Institutes of Health
Grant: R01 AR073284
National Institutes of Health
Grant: K23AR075112
NIAMS NIH HHS
Grant: K24 AR063120
CSRD VA
Grant: I01 CX001183
NIAMS NIH HHS
Grant: R01 AR070470
NCATS NIH HHS
Grant: KL2 TR003168
National Institutes of Health
Grant: 5K23AR067889-03
Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment
National Institutes of Health
Grant: 5K24AR063120-07
Outcomes Research in Rheumatic Diseases
National Institutes of Health
Grant: 5R01AR073208-04
Autoantibodies Define Scleroderma Subgroups with Distinct Relationships to Cancer
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-INF/6762/2020
MS3: New foundations for micro-services and serverless systems
National Institutes of Health
Grant: 5K23AR075112-04
Screening Chest CT to Detect Interstitial Lung Disease in Systemic Sclerosis
National Institutes of Health
Grant: 5R01AR073284-04
CFlm25 mediated alternative polyadenylation regulates fibrosis in systemic sclerosis
Bayer Corporation
Pfizer Foundation
Scleroderma Research Foundation
Bristol-Myers Squibb Foundation
Eicos Science,Inc
Horizon Pharmaceuticals
Immune Tolerance Network
Boehringer Ingelheim
FWCI
1.33
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals